Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2011-05-03 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: AUTERIVE (31190), Haute-Garonne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA MADELEINE : revenue, balance sheet and financial ratios
PHARMACIE DE LA MADELEINE is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in AUTERIVE (31190),
this company of category PME
shows in 2024 a net income positive of 140 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA MADELEINE (SIREN 532362431)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
140 136 €
102 684 €
152 857 €
166 577 €
159 768 €
198 241 €
179 498 €
180 688 €
157 053 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE LA MADELEINE generates positive net income of 140 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 157 k€ -> 140 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
140 136 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 32%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 67%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
31.632%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
67.308%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA MADELEINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
288.43
210.312
157.343
117.869
109.085
82.995
61.058
46.385
31.632
Financial autonomy
22.87
28.621
34.248
41.801
43.69
50.116
56.257
60.962
67.308
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
31.632024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good-9 pts over 3 years
In 2024, the debt ratio of PHARMACIE DE LA MADELEINE (31.63) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
67.31%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+10 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE LA MADELEINE (67.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 136.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
136.375
Liquidity indicators evolution PHARMACIE DE LA MADELEINE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
160.032
153.665
152.816
176.379
201.828
215.569
180.052
150.382
136.375
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
136.382024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average-13 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE LA MADELEINE (136.38) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE DE LA MADELEINE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LA MADELEINE is estimated at
1 956 402 €
(range 1 362 407€ - 2 926 889€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1362k€1956k€2926k€
1 956 402 €Range: 1 362 407€ - 2 926 889€
NAF 5 année 2024
Valuation method used
Net Income Multiple
140 136 €
×
14.0x
=1 956 402 €
Range: 1 362 408€ - 2 926 890€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA MADELEINE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA MADELEINE
What is the revenue of PHARMACIE DE LA MADELEINE ?
The revenue of PHARMACIE DE LA MADELEINE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE LA MADELEINE profitable?
Yes, PHARMACIE DE LA MADELEINE generated a net profit of 140 k€ in 2024.
Where is the headquarters of PHARMACIE DE LA MADELEINE ?
The headquarters of PHARMACIE DE LA MADELEINE is located in AUTERIVE (31190), in the department Haute-Garonne.
Where to find the tax return of PHARMACIE DE LA MADELEINE ?
The tax return of PHARMACIE DE LA MADELEINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA MADELEINE operate?
PHARMACIE DE LA MADELEINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart